MAM
TMO icon

McLean Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

McLean Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279K Sell
567
-60
-10% -$32.6K 0.05% 138
2025
Q4 		$390K Hold
627
– – 0.07% 109
2025
Q3 		$341K Buy
627
+28
+5% +$13K 0.07% 121
2025
Q2 		$256K Buy
599
+8
+1% +$3.35K 0.07% 142
2025
Q1 		$248K Sell
591
-18
-3% -$9.75K 0.08% 128
2024
Q4 		$317K Sell
609
-12
-2% -$6.6K 0.1% 108
2024
Q3 		$372K Buy
621
+6
+1% +$3.55K 0.11% 92
2024
Q2 		$330K Sell
615
-91
-13% -$52.1K 0.11% 95
2024
Q1 		$416K Sell
706
-2
-0.3% -$1.12K 0.14% 83
2023
Q4 		$376K Sell
708
-60
-8% -$29K 0.14% 80
2023
Q3 		$381K Buy
768
+36
+5% +$19.2K 0.16% 78
2023
Q2 		$382K Buy
732
+7
+1% +$3.78K 0.15% 81
2023
Q1 		$418K Sell
725
-21
-3% -$11.8K 0.17% 73
2022
Q4 		$411K Sell
746
-42
-5% -$22.3K 0.14% 78
2022
Q3 		$413K Sell
788
-5
-0.6% -$2.8K 0.16% 64
2022
Q2 		$441K Buy
793
+8
+1% +$4.4K 0.18% 62
2022
Q1 		$464K Buy
785
+21
+3% +$12.1K 0.34% 55
2021
Q4 		$478K Sell
764
-174
-19% -$109K 0.18% 59
2021
Q3 		$571K Buy
938
+10
+1% +$5.49K 0.22% 49
2021
Q2 		$483K Buy
928
+20
+2% +$9.44K 0.22% 50
2021
Q1 		$445K Hold
908
– – 0.35% 46
2020
Q4 		$423K Buy
+908
New +$426K 0.37% 44

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

McLean Asset Management's TMO Position: Q1 2026 in Review

McLean Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 9.6% in Q1 2026, selling an estimated $32.6K and leaving 567 shares worth $279K. The position accounts for 0.05% of the portfolio, ranked #138.

McLean Asset Management first reported a position in TMO in Q4 2020 and has held it in 22 quarters since. The position peaked at $571K in Q3 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • McLean Asset Management held 567 shares of Thermo Fisher Scientific worth $279K as of Q1 2026.
  • McLean Asset Management sold 60 Thermo Fisher Scientific shares in Q1 2026, an estimated $32.6K.
  • Thermo Fisher Scientific made up 0.05% of McLean Asset Management's portfolio in Q1 2026, its #138 holding.
  • McLean Asset Management first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 22 quarters since.
  • McLean Asset Management's Thermo Fisher Scientific position peaked at $571K in Q3 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on McLean Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.